BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 24817416)

  • 1. Plasmablasts as a biomarker for IgG4-related disease, independent of serum IgG4 concentrations.
    Wallace ZS; Mattoo H; Carruthers M; Mahajan VS; Della Torre E; Lee H; Kulikova M; Deshpande V; Pillai S; Stone JH
    Ann Rheum Dis; 2015 Jan; 74(1):190-5. PubMed ID: 24817416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating plasmablasts/plasma cells: a potential biomarker for IgG4-related disease.
    Lin W; Zhang P; Chen H; Chen Y; Yang H; Zheng W; Zhang X; Zhang F; Zhang W; Lipsky PE
    Arthritis Res Ther; 2017 Feb; 19(1):25. PubMed ID: 28183334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IgG4-Related Disease: Clinical and Laboratory Features in One Hundred Twenty-Five Patients.
    Wallace ZS; Deshpande V; Mattoo H; Mahajan VS; Kulikova M; Pillai S; Stone JH
    Arthritis Rheumatol; 2015 Sep; 67(9):2466-75. PubMed ID: 25988916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Number of Circulating Follicular Helper 2 T Cells Correlates With IgG4 and Interleukin-4 Levels and Plasmablast Numbers in IgG4-Related Disease.
    Akiyama M; Suzuki K; Yamaoka K; Yasuoka H; Takeshita M; Kaneko Y; Kondo H; Kassai Y; Miyazaki T; Morita R; Yoshimura A; Takeuchi T
    Arthritis Rheumatol; 2015 Sep; 67(9):2476-81. PubMed ID: 25989153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of T follicular helper cells and plasmablasts with the development of organ involvement in patients with IgG4-related disease.
    Kubo S; Nakayamada S; Zhao J; Yoshikawa M; Miyazaki Y; Nawata A; Hirata S; Nakano K; Saito K; Tanaka Y
    Rheumatology (Oxford); 2018 Mar; 57(3):514-524. PubMed ID: 29253269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. De novo oligoclonal expansions of circulating plasmablasts in active and relapsing IgG4-related disease.
    Mattoo H; Mahajan VS; Della-Torre E; Sekigami Y; Carruthers M; Wallace ZS; Deshpande V; Stone JH; Pillai S
    J Allergy Clin Immunol; 2014 Sep; 134(3):679-87. PubMed ID: 24815737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative measurement of 18F-FDG PET/CT uptake reflects the expansion of circulating plasmablasts in IgG4-related disease.
    Berti A; Della-Torre E; Gallivanone F; Canevari C; Milani R; Lanzillotta M; Campochiaro C; Ramirez GA; Bozzalla Cassione E; Bozzolo E; Pedica F; Castiglioni I; Arcidiacono PG; Balzano G; Falconi M; Gianolli L; Dagna L
    Rheumatology (Oxford); 2017 Dec; 56(12):2084-2092. PubMed ID: 28977663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IgG4 levels and plasmablasts as a marker for IgG4-related disease (IgG4-RD).
    Fox RI; Fox CM
    Ann Rheum Dis; 2015 Jan; 74(1):1-3. PubMed ID: 25477133
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical value of plasmablasts in predicting disease relapse in patients with IgG4-related disease.
    Wang Y; Zhao Z; Gao D; Wang H; Liao S; Luo G; Ji X; Li Y; Wang X; Zhao Y; Li K; Zhang J; Jin J; Zhang Y; Zhu J; Zhang J; Huang F
    Clin Rheumatol; 2023 Jan; 42(1):135-143. PubMed ID: 36074221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The diagnostic utility of serum IgG4 concentrations in IgG4-related disease.
    Carruthers MN; Khosroshahi A; Augustin T; Deshpande V; Stone JH
    Ann Rheum Dis; 2015 Jan; 74(1):14-8. PubMed ID: 24651618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic Performance of Serum IgG4 Levels in Patients With IgG4-Related Disease.
    Yu KH; Chan TM; Tsai PH; Chen CH; Chang PY
    Medicine (Baltimore); 2015 Oct; 94(41):e1707. PubMed ID: 26469909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum soluble interleukin-2 receptor is a useful biomarker for disease activity but not for differential diagnosis in IgG4-related disease and primary Sjögren's syndrome adults from a defined population.
    Akiyama M; Sasaki T; Kaneko Y; Yasuoka H; Suzuki K; Yamaoka K; Takeuchi T
    Clin Exp Rheumatol; 2018; 36 Suppl 112(3):157-164. PubMed ID: 29465360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deconstructing IgG4-related disease involvement of midline structures: Comparison to common mimickers.
    Lanzillotta M; Campochiaro C; Trimarchi M; Arrigoni G; Gerevini S; Milani R; Bozzolo E; Biafora M; Venturini E; Cicalese MP; Stone JH; Sabbadini MG; Della-Torre E
    Mod Rheumatol; 2017 Jul; 27(4):638-645. PubMed ID: 27622319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B-cell depletion attenuates serological biomarkers of fibrosis and myofibroblast activation in IgG4-related disease.
    Della-Torre E; Feeney E; Deshpande V; Mattoo H; Mahajan V; Kulikova M; Wallace ZS; Carruthers M; Chung RT; Pillai S; Stone JH
    Ann Rheum Dis; 2015 Dec; 74(12):2236-43. PubMed ID: 25143523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No definite clinical features of immunoglobulin G4-related disease in patients with pulmonary nodular lymphoid hyperplasia.
    Bois MC; Sekiguchi H; Ryu JH; Yi ES
    Hum Pathol; 2017 Jan; 59():80-86. PubMed ID: 27720730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expansion of blood IgG
    Heeringa JJ; Karim AF; van Laar JAM; Verdijk RM; Paridaens D; van Hagen PM; van Zelm MC
    J Allergy Clin Immunol; 2018 May; 141(5):1831-1843.e10. PubMed ID: 28830675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rituximab for IgG4-related disease: a prospective, open-label trial.
    Carruthers MN; Topazian MD; Khosroshahi A; Witzig TE; Wallace ZS; Hart PA; Deshpande V; Smyrk TC; Chari S; Stone JH
    Ann Rheum Dis; 2015 Jun; 74(6):1171-7. PubMed ID: 25667206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated Serum IgG4 Levels in Diagnosis, Treatment Response, Organ Involvement, and Relapse in a Prospective IgG4-Related Disease UK Cohort.
    Culver EL; Sadler R; Simpson D; Cargill T; Makuch M; Bateman AC; Ellis AJ; Collier J; Chapman RW; Klenerman P; Barnes E; Ferry B
    Am J Gastroenterol; 2016 May; 111(5):733-43. PubMed ID: 27091321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating memory B cells and plasmablasts are associated with the levels of serum immunoglobulin in patients with ulcerative colitis.
    Wang X; Jiang Y; Zhu Y; Zhang M; Li M; Wang H; Gao P
    J Cell Mol Med; 2016 May; 20(5):804-14. PubMed ID: 26800315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rituximab for the treatment of IgG4-related disease: lessons from 10 consecutive patients.
    Khosroshahi A; Carruthers MN; Deshpande V; Unizony S; Bloch DB; Stone JH
    Medicine (Baltimore); 2012 Jan; 91(1):57-66. PubMed ID: 22210556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.